Determinants of ventilator associated pneumonia and its impact on prognosis: A tertiary care experience

JOURNAL TITLE: Indian Journal of Critical Care Medicine

Author
1. V. Preethi
2. Vasudev Guddattu
3. Rishikesh Kumar
4. Chiranjay Mukhopadhyay
5. Ananthakrishna Shastry
ISSN
0972-5229
DOI
10.4103/0972-5229.123435
Volume
17
Issue
6
Publishing Year
2013
Pages
6
Author Affiliations
    1. Department of Medicine, Kasturba Medical College, Karnataka, India
    1. Department of Medicine, Kasturba Medical College, Karnataka, India
    1. Department of Biostatistics, Manipal University, Manipal, Karnataka, India
    1. Department of Medicine, Kasturba Medical College, Karnataka, India
    1. Department of Microbiology, Kasturba Medical College, Karnataka, India
  • Article keywords
    Hospital acquired pneumonia, India, multidrug resistant organism, ventilator associated pneumonia

    Abstract

    Background: Ventilator associated pneumonia (VAP) is a major cause of poor outcome among patients in the intensive care units (ICU) world-wide. We sought to determine the factors associated with development of VAP and its prognosis among patients admitted to different ICUs of a Tertiary Care Hospital in India. Methodology: We did a matched case control study during October 2009 to May 2011 among patients, ≥18 years with mechanical ventilation. Patients who developed pneumonia after 48 h of ventilation were selected in the case group and those who did not develop pneumonia constituted the control group. Patients′ history, clinical and laboratory findings were recorded and analyzed. Results: There were 52 patients included in each group. Among cases, early onset ventilator associated pneumonia (EVAP) occurred in 27 (51.9%) and late onset ventilator associated pneumonia (LVAP) in 25 (48.1%). Drug resistant organisms contributed to 76.9% of VAP. Bacteremia (P = 0.002), prior use of steroid/immunosuppressant (P = 0.004) and re-intubations (P = 0.021) were associated with the occurrence of VAP. The association of Acinetobacter (P = 0.025) and Pseudomonas (P = 0.047) for LVAP was found to be statistically significant. Duration of mechanical ventilation (P = 0.001), ICU stay (P = 0.049) and requirement for tracheostomy (P = 0.043) were significantly higher in VAP. Among each case and control groups, 19 (36.5%) expired. Conclusion: We found a higher proportion of LVAP compared with EVAP and a higher proportion of drug resistant organisms among LVAP, especially Pseudomonas and Acinetobacter. Drug resistant Pseudomonas was associated with higher mortality.

    © 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved